Gold prices steady as traders assess Fed rate outlook after soft US data
Investing.com - Morgan Stanley (NYSE:MS) has raised its price target on Janus Henderson Group (NYSE:JHG) to $39.00 from $38.00 while maintaining an Equalweight rating on the stock. The company, currently trading at $43.09, has demonstrated strong financial health with a "GREAT" rating according to InvestingPro metrics, supported by a solid P/E ratio of 16.19x and an attractive dividend yield of 3.78%.
The price target increase represents a 2.6% upward revision and is based on a 10.3x target price-to-earnings ratio, according to the investment bank’s analysis.
Morgan Stanley cited better management fees as the primary driver for the adjustment, though this positive factor was partially offset by elevated operating expenses.
The firm has increased its third-quarter 2025 adjusted earnings per share estimate by 1.5% to $0.94 for Janus Henderson, reflecting these improved fee expectations despite higher costs.
Morgan Stanley also revised its full-year adjusted earnings per share forecasts upward, with 2025 estimates increasing by 2.1% to $3.61 and 2026 estimates rising by 1.8% to $3.84, based on the same dynamics of improved fees against higher expenses.
In other recent news, Janus Henderson Group has seen its stock price target raised by TD Cowen analyst Bill Katz. Katz increased the price target to $46.00, up from the previous $41.00, while maintaining a Buy rating on the stock. This adjustment follows the recent contract renewal for the CEO and a strong market rally. Katz emphasized Janus Henderson as the preferred choice within the traditional asset management sector. The analyst’s optimism is linked to the company’s long-term organic growth prospects compared to its price-to-earnings multiple. The new 12-month price target is based on 12.5 times the firm’s revised 2026 earnings estimate, up from a previous multiple of 12. Katz also pointed out that despite the company’s shares lagging behind peers year-to-date, the business model shows increasing efficacy. This is attributed to the company’s exceptional performance in 2024 and a recent slowdown in fixed income and ETF volumes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.